N.O.max ER 180 Tablets
N.O.maxā¢Ā ERĀ represents an extended-release nitric oxide precursor. Scientists now refer to nitric oxide (NO) as the āfoundationā of cardiovascular health. This tiny molecule is a vasodilator responsible for controlling blood flow to the entire body, which may help support healthy blood flow pressure and promote the health of the endotheliumāthe inside of blood vessels. With age comes diminished NO levels; thatās why since 1998, when three scientists won the Nobel Prize for their discovery of NO, researchers have been working to harness its heart-healthy activity. Today, with the application of XYMOGENās extended-release technology, that activity has been realized with N.O.max ER.*
Product Information
Product Information
Shipping & Returns
Shipping & Returns
N.O.max ER 180 Tablets
N.O.max ER 180 Tablets
N.O.maxā¢Ā ERĀ represents an extended-release nitric oxide precursor. Scientists now refer to nitric oxide (NO) as the āfoundationā of cardiovascular health. This tiny molecule is a vasodilator responsible for controlling blood flow to the entire body, which may help support healthy blood flow pressure and promote the health of the endotheliumāthe inside of blood vessels. With age comes diminished NO levels; thatās why since 1998, when three scientists won the Nobel Prize for their discovery of NO, researchers have been working to harness its heart-healthy activity. Today, with the application of XYMOGENās extended-release technology, that activity has been realized with N.O.max ER.*
Original: $111.99
-65%$111.99
$39.20Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
N.O.maxā¢Ā ERĀ represents an extended-release nitric oxide precursor. Scientists now refer to nitric oxide (NO) as the āfoundationā of cardiovascular health. This tiny molecule is a vasodilator responsible for controlling blood flow to the entire body, which may help support healthy blood flow pressure and promote the health of the endotheliumāthe inside of blood vessels. With age comes diminished NO levels; thatās why since 1998, when three scientists won the Nobel Prize for their discovery of NO, researchers have been working to harness its heart-healthy activity. Today, with the application of XYMOGENās extended-release technology, that activity has been realized with N.O.max ER.*
